Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy: The ILUvien in Postoperative CYstoid Macular eDema Study

To assess the efficacy and safety of 0.19-mg fluocinolone acetonide (FAc) intravitreal implant (Iluvien) in treating chronic postoperative cystoid macular edema (PCME) after pars plana vitrectomy. Retrospective multicentric case series in clinical settings. Patients with chronic PCME who underwent v...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology retina 2024-12, Vol.8 (12), p.1181
Hauptverfasser:	Motloch, Karolina, Soler, Vincent, Delyfer, Marie-Noëlle, Vasseur, Vivien, Wolff, Benjamin, Issa, Mohamad, Dot, Corinne, Massé, Hélène, Weber, Michel, Comet, Alban, Hitzl, Wolfgang, Matonti, Frederic, Creuzot-Garcher, Catherine, Tadayoni, Ramin, Kodjikian, Laurent, Couturier, Aude
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Dose-Response Relationship, Drug Drug Implants Female Fluocinolone Acetonide - administration & dosage Follow-Up Studies Glucocorticoids - administration & dosage Humans Intraocular Pressure - physiology Intravitreal Injections Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - etiology Male Middle Aged Postoperative Complications - diagnosis Retrospective Studies Tomography, Optical Coherence - methods Treatment Outcome Visual Acuity Vitrectomy - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!